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Abstract
Background: The revelation that the human genome encodes only ,25,000 genes and thus cannot account for phenotypic
complexity has been one of the biggest surprises in the post-genomic era. However, accumulating evidence suggests that
transcriptional regulation may be in large part responsible for this observed mammalian complexity. Consequently, there
has been a strong drive to locate cis-regulatory regions in mammalian genomes in order to understand the unifying
principles governing these regions, including their genomic distribution. Although a number of systematic approaches have
been developed, these all discount coding sequence.
Methodology/Principal Findings: Using the computational tool PRI (Pattern-defined Regulatory Islands), which does not
mask coding sequence, we identified a regulatory region associated with the gene ADAMTS5 that encompasses the entirety
of the essential coding exon 2. We demonstrate through a combination of chromatin immunoprecipitation and reporter
gene studies that this region can not only bind the myogenic transcription factors MYOD and myogenin and the E-protein
HEB but can also function as a very strong myogenic transcriptional enhancer.
Conclusions/Significance: Thus, we report the identification and detailed characterization of an exonic enhancer.
Ultimately, this leads to the interesting question of why evolution would be so parsimonious in the functional assignment of
sequence.
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Introduction
Since the discovery of the SV40 enhancer, the first enhancer
shown to regulate transcription of a mammalian gene [1],
enhancers have been defined as DNA sequence regions that can
up-regulate transcription independent of position and orientation
with respect to the gene. They have been found virtually
everywhere in the genome: upstream of genes, in 59-UTRs, within
introns, in 39-UTRs, and downstream of genes [2]. They can
operate from within hundreds of base pairs of the transcription
start site or up to 1 Mb away [3,4]. They can even direct
transcription interchromosomally [5,6]. There are also several
reports of finding them within noncoding exons [7,8]. However,
there are very few examples of them being found within coding
exons.
This does not mean that cis-regulatory regions cannot reside
within coding exons. With rapidly expanding access to genome
sequences and the development of comparative genomics tools
that can locate conserved regions across genomes, researchers are
increasingly relying on these methods to find regulatory regions.
Unfortunately, many predictive approaches, although frequently
adept at locating cis-regulatory regions, intentionally mask coding
sequence [9]. This is probably due in large part to the higher level
of conservation that would be expected in these regions, which
could pose a false positive problem for identifying cis-regulatory
elements using phylogenetic footprinting tools that simply look for
large regions of sequence conservation.
We recently reported the development of a pattern-matching-
based approach that searches for clusters of seven or more
transcription factor binding sites that are absolutely conserved in
order and in spacing across human, mouse, and rat genomes
(http://barcode.colorado.edu/pri/) [10]. We refer to these regions
as Pattern-defined Regulatory Islands (PRIs). In developing the
PRI algorithm, a conscious decision was taken to not mask these
sequences. Because PRI relies solely on the conservation of order
and spacing of transcription factor binding sites and is insensitive
to the identity of intervening bases, it is not as encumbered by the
risks of highly conserved codons. Inspection of the PRI database
revealed that 3.2% of the islands overlap to some degree with
coding sequence. Curious about the relevance of these regions, we
proceeded to test whether any of them could direct transcription in
mouse C2C12 cells, a myoblast cell line in which skeletal
myogenesis can be recapitulated in vitro. In particular, we focused
on an island (termed PRI 1) associated with the gene ADAMTS5,
which is strongly up-regulated during myogenesis. Not only does
this island contain binding sites for myogenic transcription factors,
it also completely encompasses an essential coding exon. We
reveal in the following study that the exonic PRI 1 of ADAMTS5 is
a very potent transcriptional enhancer that depends upon the
integrity of binding sites that overlap with codons.
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ADAMTS5 Harbors a PRI that Encompasses a Coding Exon
Annotation of the PRI database revealed that 3.2% of the
assembled PRIs (22,823 out of a total 703,906 PRIs) overlap at
least partially with coding sequence. In light of this figure and
given our previous success with discovering that PRIs can display
enhancer activity [10], we expected that it would be possible to
find enhancer activity associated with exon-derived PRIs. To
approach this problem, we focused on the gene ADAMTS5.I n
addition to being the aggrecanase principally responsible for the
heightened degradation of the extracellular matrix molecule
aggrecan seen in osteoarthritis [11,12], its transcript is also
strongly up-regulated in C2C12 cells after six days of differenti-
ation (4.84-, 6.7-, 8.1-fold, 3 probes) [13]. We also confirmed that
ADAMTS5 is up-regulated in our C2C12 differentiation system
using real-time PCR (Figure S1). We observed that two PRIs
associated with this gene contain E-boxes, to which myogenic
regulatory factors (MRFs) can bind, and one of these PRIs (PRI 1)
encompasses the entire exon 2. Exon 2 is an essential coding exon
as it contains half of the protease active site. There are seven
conserved binding sites distributed throughout the exon, including
two E-boxes. The other E-box-containing PRI, PRI 2, is found
entirely within an intron and is approximately 3500 base pairs
downstream of PRI 1. Figure 1A presents the composition of the
islands in greater detail. To illustrate the broader context, the
genomic locations of these PRIs mapped onto the UCSC Genome
Browser (http://genome.ucsc.edu) [14,15] are presented in Figure
S2A.
It is frequently observed that there is high conservation at
coding regions and lower conservation at noncoding regions (for
example, see Figure S2A). Supplemental Figure 2B depicts a 10-
way vertebrate Multiz alignment from Genome Browser with the
PRI custom track displayed in red and the conserved binding sites
overlayed on the track. In the sequence corresponding to PRI 1,
not only is there high cross-species conservation associated with
exon 2 (solid blue bar on the ‘‘Adamts5’’ track), but this
conservation also extends to the flanking intronic sequence
encompassed by PRI 1. Outside of the PRI region, conservation
decreases noticeably. In addition, while there is strong conserva-
tion throughout the exon, there are clear dips in conservation in
the intronic PRI sequence that corresponds to the spacing
sequence between conserved transcription factor binding sites.
This suggests that there is selective pressure for both codon
preservation and binding site preservation.
Exon-Derived PRI 1 Is Bound by Myogenic Transcription
Factors during Differentiation
As an initial assessment of whether the exonic PRI 1 of
ADAMTS5 could also function as a myogenic transcriptional
enhancer, we performed chromatin immunoprecipitation assays
with an antibody against MYOD. Intriguingly, MYOD did bind
in the region of PRI 1; in fact, the PCR signal was nearly as strong
as the 0.1% input signal (Figure 1B). By contrast, the signal for
MYOD binding in the vicinity of PRI 2 was virtually undetectable.
We followed this result up with a more comprehensive survey of
MRF and E-protein binding in C2C12 myoblasts and myotubes.
E-proteins are a ubiquitous class of proteins that, amongst various
other transcriptional roles, heterodimerize with MRFs to promote
E-box binding and synergistic transcriptional activation [16]. HEB
is the main E-protein expressed in and responsible for regulating
differentiation of C2C12 cells [17], thus we selected an antibody
that recognizes both a- and b-isoforms for immunoprecipitation.
We also chose an antibody against myogenin to probe whether
there are differences in MRF binding across this timecourse.
Figure 1C depicts the results of PCR of the positive control region
from MYOG, ADAMTS5 PRI 1, ADAMTS5 PRI 2, and a promoter
region of amylase, AMY2-1, which has been used previously as a
negative control region for MRF and HEB binding [17]. It is
apparent here that while MYOD binding is still evident at PRI 1
in myoblasts and myotubes, myogenin and HEB binding
dramatically increase in myotubes after one day of serum
deprivation. By contrast, neither of the MRFs nor HEB binds
PRI 2 at either timepoint. The observations that HEB binds PRI 1
in addition to the MRFs MYOD and myogenin and that
myogenin binding appears to be regulated during differentiation
indicates that one or more E-boxes within PRI 1 may truly be
conveying myogenic transcriptional signals.
PRI 1 Can Differentially Drive Transcription during
Myogenesis
Although it is clear that multiple myogenic transcription factors
can bind to PRI 1 of ADAMTS5 during C2C12 differentiation, a
key experiment in assessing whether this region can serve as a site
of transcriptional regulation is whether it can differentially regulate
reporter gene transcription. To probe this possibility, we cloned
the genomic regions corresponding to PRI 1 and PRI 2 into a
reporter vector upstream of a minimal TATA box-containing
promoter and the luciferase gene (Figure 2A, top schematic). We
then transfected the resulting constructs into C2C12 cells along
with pRL-TK for transfection normalization purposes and tracked
reporter gene activity in growing myoblasts (GM) and differenti-
ating myotubes after one day of serum withdrawal (DM D1).
Figure 2B demonstrates that PRI 1 robustly supports luciferase
gene transcription with a 9.9-fold change, essentially equivalent to
that of the MYOG positive control region and with slightly stronger
basal level activity. Conversely, PRI 2 is incapable of enhancing
transcriptional output above that of the background minimal
promoter construct (minTATA), which is in line with its
transcription factor binding properties. This strongly indicates
that PRI 1 of ADAMTS5 is a bona fide cis-regulatory region.
The Exonic Portion of PRI 1 is Necessary for Enhancing
Transcription
Having shown that PRI 1 can drive reporter gene expression
and given that PRI 1 is comprised of sequence derived from both
an exon and introns, an obvious question asks what the
dependence on these regions is in driving transcription. Towards
answering this question, we made two mutants of the wild-type
PRI 1 reporter construct (Figure 2A, middle and bottom
schematics). In the first (termed ‘‘D exon’’), we deleted the exonic
sequence from the middle of the island, and in the second (termed
‘‘exon only’’), we deleted the intronic sequence flanking the exon.
In comparing the ability of these constructs to promote luciferase
gene expression during C2C12 differentiation to that of the wild-
type construct (Figure 2C), it is readily apparent that both can
barely support transcription above the minTATA construct and
that there is absolutely no induction when differentiation is
triggered. It thus appears that the exonic sequence is necessary but
not sufficient to enhance transcription. The PRI hypothesis
predicts this outcome as both regions contain binding sites
conserved in order and in spacing.
Both Intronic and Exonic Binding Sites Contribute to
Enhancer Activity
We next evaluated the contribution of individual binding sites to
luciferase signal by making a number of point mutations within
Exonic Encoded Enhancer
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literature. We focused on the three E-boxes, the GR site, the Myb
site, and the H-APF-1 site. The specific mutations along with the
literature source for each are summarized in Table 1. We then
introduced the mutant constructs into the C2C12 cells and
analyzed the resultant reporter gene activity. As revealed by
Figure 1. ADAMTS5 PRI 1 Is Bound by Myogenic Transcription Factors in C2C12 Myoblasts and Myotubes. (A) Schematics of PRI 1 and
PRI 2 of ADAMTS5. Colored boxes represent transcription factor binding sites and are labeled. E-boxes, used to find the PRIs, are labeled in red. The
portion of PRI 1 that derives from exon 2 is indicated. Numbering is with respect to the start codon. (B) Chromatin immunoprecipitation using a
MYOD antibody in formaldehyde-fixed, sonicated myoblast and myotube (Day 1 of differentiation) lysate indicates that PRI 1 but not PRI 2 is bound
during differentiation. Input refers to 0.1% pre-immunoprecipitation input, Ø refers to no primary antibody, MYOD refers to MYOD antibody. (C)
Chromatin immunoprecipitation with MYOD, MYOG, and HEB antibodies. mMYOG PRI 5 serves as positive control, mADAMTS5 PRI 2 and mAMY2.1
serve as negative controls. Input refers to 0.1% pre-immunoprecipitation input, Ø refers to no primary antibody, MYOD refers to MYOD antibody,
MYOG refers to MYOG antibody, HEB refers to HEB antibody.
doi:10.1371/journal.pone.0002184.g001
Exonic Encoded Enhancer
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activity and fold change during myogenesis are E-boxes 2 and 3,
which are exonic and intronic respectively (numbering according
to Figure 1A). E-box 1 (exonic) along with the GR site (exonic)
appear to make relatively minor contributions. The effects of
mutating the Myb site (exonic) and the H-APF-1 site (exonic) are
Figure 2. PRI 1 Drives Reporter Gene Transcription during Myogenesis and Is Dependent Upon Exon-derived Sequence. (A)
Schematic of reporter gene vector construction and deletion mutants. PRIs are placed upstream of a TATA box and the firefly luciferase gene. I1 refers
to sequence from Intron 1, E refers to Exon 2 sequence, I2 refers to Intron 2 sequence. (B) C2C12 cells were transfected with luciferase reporter
plasmids and normalized with a renilla reporter plasmid driven by the thymidine kinase promoter. Cells were harvested as growing myoblasts (GM)
and as differentiating myotubes one day after serum withdrawal (DM D1). minTATA is the background vector with a TATA box and no upstream
cloned regions. Each bar represents the average of three independent experiments and error bars denote +/2 SD. (C) Luciferase assay performed as
in B.
doi:10.1371/journal.pone.0002184.g002
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obviously conform to the consensus site CANNTG, E-boxes 2 and
3 have the exact same sequence (CAGCTG) and contribute the
most to luciferase signal while E-box 1 is different at the N
positions (CATGTG). In summary, both exonic and intronic
binding sites contribute to the observed PRI 1-driven reporter
gene activity.
Assessing the Dependence on PRI Orientation
The traditional definition of an enhancer is a genomic region
that promotes transcription independent of position and orienta-
tion. In order to assess whether PRI 1 is independent of
orientation, we reversed the orientation of PRI 1 (rPRI1) in the
reporter vector. We then transiently transfected this construct
along with the wild-type into the C2C12 cells and harvested Day 0
and Day 1 timepoints. In comparing to the original construct, it is
apparent that, while there is an approximate 2-fold drop in signal,
the fold change remains essentially the same (Figure 4). This
suggests that PRI orientation may only slightly contribute to
enhancer activity. It is possible that, if the PRI were moved farther
away from the promoter region, orientation would be even less of
a factor because there would be fewer constraints on DNA spatial
arrangement such that the factors bound at the PRI could more
easily be positioned with respect to the general transcription
machinery.
Discussion
Through this work, we have shown that ADAMTS5 PRI 1 is a
transcriptional enhancer that is derived in part from exonic
sequence and that depends upon transcription factor binding sites,
particularly E-boxes, from both the exonic and intronic portions of
the island. This exon (exon 2) contains coding sequence essential to
functional ADAMTS5 protein as it harbors half of the active site
residues. Therefore, this is not a case of alternative start sites or
noncoding exons explaining the presence of an enhancer.
How does one rationalize the dual nature of this sequence?
There are a couple of potential mechanisms that could explain this
co-existence. Although this island contains ADAMTS5 exon 2, it is
possible that it does not act to regulate transcription of ADAMTS5
itself. It may instead participate in long range interactions to
control another gene(s). The two flanking genes surrounding
ADAMTS5 are ADAMTS1 and N6amt1 (Hemk2). ADAMTS1,a n
aggrecanase in the same family as ADAMTS5, is approximately
59,000 base pairs downstream of ADAMTS5, but it is only up-
regulated about 2-fold during myogenesis [13]. N6amt1 (a
predicted methyltransferase) is 1.5 megabases upstream of
ADAMTS5 but is expressed very poorly in C2C12 cells and
changes less than 2-fold during myogenesis. While these could be
targets for PRI 1-directed regulation, the possibility seems rather
remote as they do not exhibit expression patterns consistent with
muscle-specific genes. Still, PRI 1 may regulate some other genes
more distal than these.
Alternatively, it may indeed regulate expression of ADAMTS5.
It is worth noting that the PRI algorithm predicts another island,
PRI 0, directly upstream of ADAMTS5 (see Figure S2A for
genomic position). According to the NCBI RefSeq annotation
[18], PRI 0 is 279R+35 with respect to the transcription start
site and 2937R28 2 3w i t hr e s p e c tt ot h es t a r tc o d o n .I th a r b o r s
a conserved TATA box (2829 with respect to the start codon,
+29 with respect to the RefSeq transcription start site). If PRI 1
physically interacts with PRI 0, this could provide a mechanism
to explain the enhancer activity of PRI 1 in regulating
transcription of ADAMTS5 itself. Although it is counterintuitive
to think that an enhancer could reside within an exon as this
could present problems for the transcriptional machinery
accessing this sequence, there are myriad examples of enhancers
Table 1. Summary of binding site mutations.
Binding Site Mutation Reference
E-box (3) CANNTGRCANNTa Cheung et al. 2007 [10]
H-APF-1 CTGGGAARCTGGGgA Majello et al. 1990 [23]
GR TGTTCTRTGaTCT Dahlman-Wright et al. 1990 [24]
Myb ATTGAARggaGAt Nicolaides et al. 1991 [25]
Point mutations made for each binding studied and literature sources for these
mutations.
doi:10.1371/journal.pone.0002184.t001
Figure 3. Intronic and Exonic Binding Sites Contribute to Transcriptional Output of PRI 1. (A) Luciferase results of reporter constructs of
PRI 1 harboring point mutations in PRI 1 according to Table 1.
doi:10.1371/journal.pone.0002184.g003
Exonic Encoded Enhancer
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yet this is obviously overcome. It is possible that a chromosomal
loop forms only to enhance the initial events in transcription and
that once the process has begun, the downstream sequence
disengages and is free to be transcribed. Alternatively, this loop
could be maintained throughout transcription but the DNA
template is threaded through it as the transcript is synthesized.
One curious feature of this study is that, although there is strong
differential reporter gene activity, MYOD binding does not appear
to change between growing myoblasts and differentiating
myotubes. The difference in activation but lack of change in
MYOD ChIP could be explained by the strong recruitment of
MYOG and the E-protein HEB upon the onset of differentiation.
Perhaps MYOD positions the DNA and facilitates transcription by
interacting with the canonical TFIID complex in myoblasts, but,
having effected the necessary chromosomal arrangement, is
swapped for a myogenin/HEB complex upon differentiation,
which promotes even stronger transcriptional output.
Two separate E-boxes in the ADAMTS5 exonic enhancer are
required for robust transcriptional activation upon myogenic
differentiation. This property is shared by the muscle-specific
creatine kinase enhancer in which a pair of E-boxes has been
shown to be required for cooperative binding to MYOD and
subsequent transcriptional activation [19]. It has been speculated
that multiple site recognition is important for decoding the
concentration of MYOD and stably engaging transcription
machinery [19]. Our result is consistent with this notion. Beside
E-boxes, there are a number of other transcription factor binding
sites in the ADAMTS5 enhancer with invariant arrangement of
spacing and orientation across human, mouse, and rat genomes.
Perturbation of several binding sites can individually lead to a
dramatic and nonlinear reduction in the ADAMTS5 enhancer
function (Figure 3). The requirement for the precise organization
of this cis-regulatory element to regulate myogenic transcription
suggests that this exon-encoded sequence element is a bona fide
transcriptional enhancer.
Apart from the novelty associated with finding an exonic
enhancer, the transcriptional regulation of ADAMTS5 is an
interesting topic in itself. High expression of this gene is strongly
associated with osteoarthritis and mice that are homozygous for
a catalytically inactive ADAMTS5 are protected against
osteoarthritis when challenged with physical or chemical joint
injury [11,12]. The discovery of the role of ADAMTS5 in
osteoarthritis was a major step forward in understanding the
pathology of this disease and presented an obvious target for
drug development. Understanding how ADAMTS5 expression is
regulated and identifying a region suitable for screening libraries
of compounds for a small molecule that can inhibit transcription
of ADAMTS5 could prove very useful in the pursuit of
osteoarthritis therapies. This work may provide such a region
in the form of PRI 1.
The exon-derived enhancer PRI 1 is not an isolated
phenomenon. Enhancer activity has been reported to be
associated with exon 6 of keratin 18 [20], although the key AP-1
binding site is not evolutionarily conserved as the same region in
the rat genome does not contain this site and it only leads to a
three- to four-fold increase in reporter gene activity above the
basal promoter. In contrast, PRI 1 elicits a 100-fold increase. We
also considered another PRI that overlaps with coding sequence of
the gene IGF2, which is up-regulated about 7-fold upon myogenic
differentiation (illustrated schematically in Supplemental Figure
S3A) [13]. MYOD can also occupy this region in myoblasts and
myotubes as evidenced by ChIP assay (Supplemental Figure 3B). A
luciferase reporter gene assay (Supplemental Figure 3C) indicates
that this region possesses enhancer activity as it drives expression
22-fold above the minimal TATA reporter in the basal state,
essentially equivalent to the positive control region from MYOG
(22-fold above minimal TATA in the basal state).
In summary, we have demonstrated that cis-regulatory regions
can overlap with coding sequence as showcased by PRI 1 of
ADAMTS5. Moreover, we have convincing evidence that enhancer
activity associated with this sequence depends upon both exon-
and intron-derived transcription factor binding sites. It will be of
great interest in the future to systematically determine how
widespread exon-derived enhancers are throughout mammalian
genomes.
Figure 4. PRI Orientation Contribution to Transcriptional Output. (A) Luciferase results of reverse reporter construct of PRI 1.
doi:10.1371/journal.pone.0002184.g004
Exonic Encoded Enhancer
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Real-time PCR
Total RNA was prepared from C2C12 cells using an RNeasy kit
(Qiagen) according to the manufacturer’s instructions. It was then
reverse transcribed with Transcriptor First Strand cDNA Synthe-
sis Kit using Anchored oligo-(dT)18 (Roche). The real-time PCR
experiment was performed using LightCycler FastStart DNA
Master(PLUS) SYBR Green I following the manufacturer’s
instructions on a Light Cycler 2.0 (Roche). Expressions were
normalized to the control gene EPB7.2, a gene whose expression
does not significantly change during myogenesis and one we used
successfully in the past [10]. The primer pair used for real-time
PCR analysis of ADAMTS5 was the same sequence reported in
[12]. The primer pair used for TNNI2 was from the Roche
Universal Probe Library: 59-AGGTGAAGGTGCAGAAGAGC;
59-TTGCCCCTCAGGTCAAATAG.
Plasmids and Mutagenesis
We cloned PRIs into the KpnI-PstI site of p3APP-lux in the
same manner described in [21]. Point mutations and deletions
were generated with the Quikchange II kit (Stratagene) per the
manufacturer’s instructions.
Cell Lines and Reporter Gene Assays
C2C12 mouse myoblasts were a kind gift from Dr. Leslie
Leinwand and were cultured and transfected as detailed in [10].
Luciferase assays were normalized to pRL-TK. Reporter gene
assays were performed using the Dual Luciferase kit (Promega)
according to the manufacturer’s instructions and were read using a
Dynex luminometer.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation assays were performed as
described in [10]. The primers used for this analysis were designed
using Vector NTI Advance 10 (Invitrogen). Primer sequences were
as follows:
mADAMTS5 PRI 1:
59-GTTGGGACCATATGTTCTCC
59-CATCTGAACCAGAAGAAATCTG
mADAMTS5 PRI 2:
59-GGTTGGTACCAATAATAAATATTTCACCTG
59-AAAACTGCAGTCACTTAGCACATTTTATAA
mAMY 2.1 promoter (as described in [22]):
59-TCAGTTGTAATTCTCCTTGTACGG
59-CCTCCCATCTGAAGTATGTGGGTC
mMYOG
59-TACAGGCCTTGCTCAGCTC
59-TGTGGGAGTTGCATTCACTG
Supporting Information
Figure S1 ADAMTS5 Is Induced during C2C12 Differentiation.
Real-time PCR analysis of mouse ADAMTS5 and mouse TNNI2
(positive control). Fold change in transcript level of the indicated
genes relative to the control gene EPB7.2 was determined by real-
time PCR. D0, D1, and D4 refer to days of C2C12 differentiation.
Found at: doi:10.1371/journal.pone.0002184.s001 (0.10 MB TIF)
Figure S2 ADAMTS5 Harbors a PRI Encompassing Coding
Exon 2. (A) A Genome Browser (http://genome.ucsc.edu) view of
the mouse ADAMTS5 gene with PRI and track displayed above.
PRI predicts a regulatory region that spans Exon 2. (B)
Phylogenetic conservation of PRI 1 and surrounding genomic
sequence. 10-way vertebrate Multiz alignment from Genome
Browser with conserved binding sites overlayed on the red PRI
track.
Found at: doi:10.1371/journal.pone.0002184.s002 (9.02 MB TIF)
Figure S3 A PRI Associated with IGF2 Is a Transcriptional
Enhancer. (A) Schematic of conserved binding sites in PRI 1. (B)
ChIP assay reveals MYOD binding in myoblasts (D0) and
myotubes (D1 after serum withdrawal). (C) Luciferase assay
reveals IGF2 PRI 1 enhances basal level transcriptional activity in
C2C12 cells.
Found at: doi:10.1371/journal.pone.0002184.s003 (0.71 MB TIF)
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